Accelerating cures for cancer by integrating discoveries in biology with innovative technology

The Mark Foundation for Cancer Research funds groundbreaking science across all cancer types through grants to individual investigators and multi-disciplinary teams, as well as venture investment in early-stage companies. Here’s a snapshot of our portfolio since our founding in 2017.

SINCE 2017

209 Research Grants

Over $150 Million Awarded


          • 20% Basic Research
          • 2% Clinical Research
          • 15% Technology Innovation
          • 12% Therapeutic Discovery
          • 51% Translational Science

          SINCE 2017

          Investments in 6 Companies

          Over $20 Million Invested


                  • 32.3% Diagnostics
                  • 18.1% Cell & Gene Therapy
                  • 19.9% Small Molecule Therapy
                  • 29.8% Biologics

                  latest news